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The last decade has seen an explosion in genome-wide association studies (GWAS) in many 
diseases. With these – and its worth reminding ourselves that this is the primary goal of 
GWAS - have come valuable insights into pathogenic pathways. Some have been predictable 
(for example variants affecting antigen presentation, co-stimulation and T-cell responses in 
immune mediated diseases) and others unexpected (for example autophagy in Crohn’s 
disease). Until recently such studies had been performed in disease cohorts specifically 
ascertained for the purpose, with clear evidence that the larger the cohort the more loci will 
be found [1]. 
Such disease-specific cohorts with well-defined phenotypes can be assembled where there 
are engaged clinical communities, but can be tricky to ascertain for more general traits. Into 
this category falls diverticular disease. This ultimately affects up to 50% of the population 
but was poorly studied at a genetic level until recently, despite clear evidence for its 
relatively high heritability [2,3].  In the current issue of Gut. Schafmayer et al report on a 
large-scale analysis using clinical and genetic data from the UK Biobank. This population 
cohort totals 500,000 individuals among whom ~32,000 have a recorded diagnosis of 
diverticular disease according to ICD9/10 coding. The authors went on to replicate their 
findings in a hospital-based case-control cohort [4]. Interestingly, a similar approach was 
recently deployed by by Maguire et al, using the same UK biobank ‘discovery’ dataset and a 
separate independent hospital-based registry as replication cohort [5]. The latter study 
identified 39 susceptibility loci for diverticular disease and showed that candidate genes 
reside in plausible biological pathways involved in cell-cell adhesion, membrane transport 
signalling and intestinal motility.  
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In the current paper by Schafmayer et al 48 susceptibility loci were identified for diverticular 
disease at a genome wide significant statistical threshold with consistent directionality in the 
discovery and replication cohorts. Of these, twelve regions were novel compared to the 
previous publications. GWAS loci usually harbour multiple genes and it is frequently unclear 
which gene is actually causal. The authors therefore performed a series of downstream in 
silico analyses to prioritize candidate genes within each locus. To the extent that these 
approaches have refined the associations seen, the authors highlighted one gene per locus, 
identified the fact that many of their signals map to introns (non-coding inserts in genes) and 
analysed layer-specific mRNA expression and fluorescence immunohistochemical staining in 
colonic biopsies. Of note, it appears that some degree of manual curation was used in the 
fine mapping routines, and with this the concern that some bias regarding likely causal genes 
might have bled into the final results.  Nevertheless, novel insights into the pathophysiology 
of diverticular disease are derived, with the suggestion that it is a disorder of intestinal 
neuromuscular function, mesenteric vascular smooth muscle function and connective fibre 
support. These therefore overlap at least to a significant extent with the conclusions of 
Maguire et al. At this stage these mechanisms must be viewed as hypotheses to be tested. 
Confirmation requires more detailed genetic mapping, ascertainment of correlation between 
the associated genetic variants and gene expression in relevant cell types, and interrogation 
of their functional impact.  
Now what to think of the methodology deployed in the current study? Inevitably there are 
some trade-offs when using a population cohort as opposed to a clinical cohort, not least in 
the definition of the disease under study. Schafmayer et al used ICD10 coding (K57) to define 
the case group, which includes both diverticulitis and diverticulosis. Anyone familiar with 
coding in the clinical setting will be aware of its potential inaccuracies, not least for a 
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condition such as diverticulosis where many affected individuals are asymptomatic and 
others may be diagnosed with the condition in the absence of objective evidence and where 
the true diagnosis is for example irritable bowel syndrome. Further, given the high 
prevalence of diverticular diseased in the population, and its increase with age, one might 
suppose that mis-specification for ‘case’ and ‘control’ status (the latter including many ‘not 
yet affected’) would be an issue. It seems that Schafmayer et al used a rather more inclusive 
definition than the study of Maguire et al, and with the larger sample identified more loci at 
genome-wide significance. As has been well recognised previously, in genetics studies of 
common disease cohort size and statistical power really count, even if this comes with some 
loss of phenotyping accuracy. 
While the potential diagnostic imprecision inherent in a population database such as the UK 
Biobank might be viewed as a weakness, the very fact that the cohort is broadly 
representative of the whole population rather than specifically collected disease cohorts 
itself provides an important ‘real world’ context for genetic findings. There is a large danger 
based on the published literature that clinicians view genetic results as more powerful and 
of greater deterministic value than they actually are. A recent publication highlights this by 
showing that the penetrance of causal mutations for many monogenic conditions has 
probably been substantially over-estimated due to their derivation from studies based on 
tertiary referral cohorts [6].  
The UK Biobank is a prospective cohort study on ~500,000 population-based individuals [7]. 
For each participant a large set of phenotypes (including ICD codes as used in the current 
study), health related measurements, diet and lifestyle data and biomarkers are available. 
There are ambitious plans to link to primary healthcare records and prescribing data, as well 
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as possibly collecting stool samples to complement the DNA and data already collected.  
GWAS has been performed on nearly the whole cohort using an array with >750,000 genetic 
markers. This unprecedented open access database has been made available to the research 
community, and – given the size of the cohort - represents a rich resource for genetic studies 
into common disease. For many GI disorders the numbers of affected individuals within the 
UK biobank is substantial. For example, >18,000 are recorded to have cholelithiasis - more 
than double the number of individuals included in the largest GWAS meta-analysis on 
gallstone disease to date [8].  Similar numbers of individuals have e.g. gastro-oesophageal 
reflux disease, colorectal polyps or irritable bowel syndrome. For each of these conditions 
there is adequate statistical power to detect genetic associations with high confidence, as 
nicely shown by the two studies on diverticular disease. Furthermore, other Biobanks are 
also coming on-stream. In the northern part of the Netherlands ‘Lifelines’, a three 
generations longitudinal cohort study of 165,000 participants, will have genetic data 
available soon, allowing for similar analyses or joint analyses with UK Biobank results [9].  
These resources represent a fantastic chance for researchers to identify genetic risk factors, 
pathogenetic mechanisms and potential drug targets across the range of GI disease,  as was 
done for diverticular disease. To date of the >1000 genetic studies approved by UK Biobank 
only a limited number relate to GI disease (see https://www.ukbiobank.ac.uk/approved-
research). This is not good enough. Our research community needs to wake up. This is a 
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